tradingkey.logo
tradingkey.logo
Search

QuidelOrtho Corp

QDEL
Add to Watchlist
18.250USD
+0.070+0.39%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.24BMarket Cap
LossP/E TTM

More Details of QuidelOrtho Corp Company

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp Info

Ticker SymbolQDEL
Company nameQuidelOrtho Corp
IPO dateFeb 01, 1991
CEOBlaser (Brian J)
Number of employees6600
Security typeOrdinary Share
Fiscal year-endFeb 01
Address9975 Summers Ridge Road
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18585521100
Websitehttps://www.quidelortho.com/
Ticker SymbolQDEL
IPO dateFeb 01, 1991
CEOBlaser (Brian J)

Company Executives of QuidelOrtho Corp

Name
Name/Position
Position
Shareholding
Change
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%

FAQs

Who are the top five shareholders of QuidelOrtho Corp?

The top five shareholders of QuidelOrtho Corp are: Dr. Kenneth F. Buechler, Ph.D.

How many institutions hold shares of QuidelOrtho Corp (QDEL)?

As of 2026Q1, 619 institutions hold shares of QuidelOrtho Corp, with a combined market value of approximately 88.33M, accounting for 129.53% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -14180850.00.

What is the biggest source of revenue for QuidelOrtho Corp?

In 2026Q1, the Labs business generated the highest revenue for QuidelOrtho Corp, amounting to 373.80M and accounting for 53.41% of total revenue.